Dr. Patrick Veit-Haibach is a dual-certified Radiologist and Nuclear Medicine Physician currently serving as the Deputy Radiologist-in-Chief, Director of the PET/MR program, Division Head Abdominal Imaging and Theranostic Lead at the Joint Department Medical Imaging (JDMI), Toronto, Canada. He is Full Professor of Radiology and Nuclear Medicine at the Department Medical Imaging at the University of Toronto.
Over the course of his career so far, he has published > 240 articles, multiple book chapters and has been Editor/Co-Editor for four books in molecular/hybrid imaging. He is currently one of the main PI’s at UHN building a comprehensive Theranostic Program. He was one of the world’s first users of PET/MR and evaluated the PET/MR through its prototype phase to market approval.

The speaker discloses the following relationships:
• Receipt of IIS grants from Bayer Switzerland, Roche Pharmaceuticals, Siemens Healthineers, and GE Healthcare.
• Participation in industry-sponsored theranostic trials, including Novartis, RayzeBio, and Fusion.
• Service on the advisory board for Novartis and Eli Lilly.
• Receipt of IIS trial support from Pentixapharm and Siemens Healthineers.
• Receipt of speaker fees and travel support from Siemens Healthineers and GE Healthcare.
• Receipt of speaker fees from the Ontario Association of Radiologists, JCA PET/CT course, Taiwan Oncology Society, Astellas, and Novartis.
• Receipt of editor fees from Springer Nature.
• Receipt of reviewer compensation from Wellcome Trust.
• Receipt of strategic panel advisory compensation and travel support from the German Cancer Center.